10 Things to Know About Polymyositis and Muscle Inflammation

Polymyositis is a rare inflammatory muscle disease that causes progressive muscle weakness, most often in muscles near the center of the body. These include the shoulders, upper arms, hips, thighs, and neck. Many people first notice trouble climbing stairs, rising from a chair, lifting objects, reaching overhead, or holding the head up for long periods. Because the symptoms may develop slowly, polymyositis can sometimes be mistaken for aging, overuse, fatigue, or ordinary muscle strain.

Understanding polymyositis and muscle inflammation can help people recognize when weakness deserves medical attention. This condition is usually considered part of a broader group of inflammatory myopathies, where the immune system is involved in attacking muscle tissue. It can also affect swallowing, breathing, joints, and daily mobility in some cases. This article explains 10 things to know about polymyositis, including symptoms, diagnosis, treatment, and why early care can help protect strength and quality of life.

What Is Polymyositis?

Polymyositis is a rare inflammatory muscle disease that causes ongoing weakness in the muscles used for movement. It usually affects muscles close to the center of the body, such as the shoulders, upper arms, hips, thighs, and neck. Because these muscles help with daily movement, people with polymyositis may struggle to climb stairs, rise from a chair, lift objects, reach overhead, or hold their head up for long periods.

This condition happens when the immune system becomes involved in attacking or inflaming healthy muscle tissue. The weakness often develops slowly over weeks or months, which can make it easy to mistake for fatigue, aging, or ordinary muscle strain. Some people may also have muscle tenderness, joint discomfort, trouble swallowing, or breathing problems if other muscles are affected.

Polymyositis usually needs medical evaluation because untreated muscle inflammation can lead to worsening weakness over time. Doctors may use blood tests, muscle enzyme tests, MRI, electromyography, or muscle biopsy to help confirm the diagnosis. Treatment often includes medicines to reduce inflammation, along with physical therapy to help protect strength, movement, and independence.

Symptoms of Polymyositis: What Are the Primary Signs of Muscle Weakness?

The primary signs of Polymyositis are symmetrical, progressive muscle weakness affecting the muscles closest to the trunk of the body, often accompanied by profound fatigue and difficulty with daily activities. This weakness is not sudden but develops over a period of weeks to months, making it distinct from acute muscle injuries. Understanding these hallmark symptoms is the first step in recognizing this complex autoimmune condition and seeking appropriate medical evaluation. The presentation of these signs can vary in intensity from person to person, but the underlying pattern of proximal, symmetrical weakness is a consistent diagnostic clue.

To understand this better, it is crucial to break down the specific characteristics of the muscle weakness and the other common symptoms that create the clinical picture of Polymyositis.

Clinical Overview: What is Polymyositis?

To define polymyositis accurately, it is classified as a rare, chronic inflammatory myopathy that triggers an abnormal autoimmune response against the body’s own skeletal muscle fibers. The fundamental polymyositis meaning centers on widespread, systemic muscle inflammation that results in structural tissue breakdown.

                       [The Structural Pattern of Polymyositis]
                                          │
         ┌────────────────────────────────┴────────────────────────────────┐
         ▼                                                                 ▼
 [Proximal Muscle Distribution]                                  [Symmetrical Presentation]
 - Targets areas closest to the torso                            - Affects both sides of the body equally
 - Hip & pelvic girdle (difficulty rising)                       - Balanced pattern of muscle weakness
 - Shoulder girdle (difficulty lifting)                          - Key indicator for clinical evaluation

Recognizing the earliest symptoms of polymyositis is essential for guiding patients toward a timely medical evaluation. Because the presentation overlaps with other neuromuscular diseases, mapping out this unique pattern of weakness is the vital first step toward an accurate polymyositis diagnosis.

Proximal and Symmetrical Muscle Involvement

The defining feature of polymyositis is muscle weakness that targets the proximal muscles—those located closest to the center of the body—and presents symmetrically on both sides.

• Hip and Thigh Muscles: Weakness in the pelvic girdle makes lower body movements exceptionally difficult. Patients often struggle to rise from a low chair or from a seated position on the floor without using their arms for leverage. Climbing stairs, stepping into a vehicle, or standing up from a low toilet seat become exhausting daily challenges.

• Shoulder and Upper Arm Muscles: When the shoulder girdle is compromised, lifting objects becomes a primary hurdle. Individuals may find it difficult to lift a gallon of milk, reach high shelves, or raise their arms to wash and brush their hair.

• Neck Muscles: Inflammation of the neck flexor muscles can lead to weakness where a person struggles to hold their head upright. This can cause persistent neck soreness and makes driving, reading, or working at a computer difficult.

The Nature of Progressive Weakness

The muscle weakness in polymyositis develops gradually and insidiously over a period of weeks or months. This slow, steady decline helps doctors rule out an acute polymyositis flare or sudden neurological events like a stroke.

• Initial Stages: Symptoms begin subtly. An individual might notice unexplained exhaustion after minor exertion or find climbing a flight of stairs unusually taxing. They may begin using their arms to push off a sofa without consciously realizing it.

• Intermediate Stages: Over subsequent weeks, the weakness becomes undeniable. Holding onto handrails tightly becomes a necessity, carrying groceries requires frequent rests, and patients begin avoiding soft, deep chairs due to the physical effort required to stand up.

• Advanced Stages: Without intervention, the inflammation continues to damage muscle tissue. Over several months, the loss of strength can become severe, leaving individuals struggling to roll over in bed, lift their arms above their shoulders, or walk independently.

Systemic and Extra-Muscular Signs

While muscle weakness is the core complaint, polymyositis symptoms frequently extend beyond skeletal tissue, reflecting the systemic nature of this autoimmune condition.

• Debilitating Fatigue: This is a deep, overwhelming exhaustion that cannot be resolved by rest. It is driven by active systemic inflammation and the extra physical effort the body requires to move weakened limbs.

• Difficulty Swallowing (Dysphagia): If the disease targets the muscles of the pharynx and upper esophagus, patients may experience coughing, choking during meals, or a sensation of food getting stuck. This is a serious clinical sign that carries a risk of malnutrition or aspiration pneumonia.

• Joint Pain and Stiffness (Arthralgia): Widespread inflammation can cause aching, stiffness, and minor swelling in the wrists, hands, knees, and ankles, sometimes mimicking rheumatoid arthritis.

• Shortness of Breath (Dyspnea): If inflammation weakens the diaphragm or the chest wall muscles, breathing effort is reduced. Furthermore, the underlying autoimmune process can cause interstitial lung disease (ILD), which involves scarring of the lung tissue and requires careful management.

Diagnostic Impact: During a clinical polymyositis diagnosis, a physician will evaluate these combined systemic signs alongside specialized blood tests (such as elevated creatine kinase levels), electromyography (EMG), and a definitive muscle biopsy to confirm the condition.

Causes of Polymyositis: What Triggers This Autoimmune Muscle Disease?

The exact cause of Polymyositis is unknown, but it is triggered by an autoimmune response where the body’s immune system mistakenly attacks its own muscle tissue, leading to chronic inflammation and damage. While the specific catalyst for this immune system malfunction remains unidentified, it is understood to be a complex interplay of genetic predisposition and potential environmental factors.

This autoimmune foundation is central to understanding why the disease develops and how treatments are designed to manage it. The immune system, designed to defend against foreign invaders like bacteria and viruses, becomes misdirected and targets the body’s own healthy cells.

To understand better, exploring the specific immune mechanisms and identifying the populations most at risk provides crucial insight into the origins of Polymyositis.

The Cellular Mechanisms of Immune System Aggression

In a healthy individual, cytotoxic T-cells act as specialized defense units that seek out and destroy virus-infected or cancerous cells. In polymyositis, these cells are incorrectly activated and sent to destroy healthy muscle tissue.

Loss of Self-Tolerance: For reasons that are not completely understood, the immune system loses its ability to recognize “self” tissue. An external catalyst alters the way muscle proteins are presented, triggering an aggressive immune response.

Endomysial Inflammation: Once activated, CD8+ cytotoxic T-lymphocytes actively move into the muscles. They surround and directly pierce individual, healthy muscle fibers. This pattern of direct cellular invasion inside the muscle bundle (endomysial inflammation) is a hallmark finding during a polymyositis diagnosis. It allows pathologists to distinguish it from dermatomyositis, where the inflammation primarily gathers around nearby blood vessels.

Cellular Destruction and Fibrosis: Upon invading the muscle fiber, the T-cells release destructive proteins like perforin and granzymes. These chemicals punch holes in the muscle cell membranes, causing the cells to die. As muscle cells break down, the body tries to patch the damage. However, the ongoing autoimmune attack blocks healthy muscle repair. Over time, healthy muscle fibers shrink (atrophy) and are replaced by rigid connective tissue (fibrosis), leading to permanent weakness.

Risk Factors and Demographic Profiles

Polymyositis is a rare condition, affecting roughly 1 in 100,000 people globally. While it can develop at any time, looking at who is most at risk provides important clues about how the disease operates:

Age and Gender Distribution: The disease most commonly appears in adults between the ages of 30 and 60. Women develop the condition roughly twice as often as men. This strong gender imbalance suggests that hormonal influences and X-chromosome variations play a major role in driving the immune system toward autoimmunity.

Genetic Predisposition: Polymyositis is not passed down in a simple parent-to-child pattern. However, certain Human Leukocyte Antigen (HLA) genes—which are responsible for helping the immune system tell the difference between the body’s own cells and foreign invaders—are strongly linked to an increased risk of developing inflammatory muscle diseases.

Environmental Triggers and Overlap Syndromes

The current medical consensus is that polymyositis is triggered when an environmental factor activates a dormant genetic vulnerability.

Cancer Screening Importance: Because the immune system’s response to an unrecognized tumor can accidentally trigger polymyositis symptoms, adults diagnosed with this condition—especially those over 50—typically undergo comprehensive cancer screenings to rule out an underlying malignancy.

Diagnosis of Polymyositis: How Do Doctors Confirm the Condition?

Doctors confirm Polymyositis through a comprehensive evaluation that combines a physical examination, blood tests, electrical tests of muscles and nerves, imaging studies, and ultimately, a muscle biopsy. No single test can definitively diagnose the condition; rather, the diagnosis is made by piecing together evidence from multiple sources to rule out other possible causes of muscle weakness.

This multi-faceted approach is necessary because many other conditions, from neurological disorders to side effects of medication, can mimic the symptoms of Polymyositis. The goal is to build a strong case based on a convergence of findings that all point toward this specific inflammatory myopathy.

Next, understanding the specific diagnostic tools used is essential to appreciate the thoroughness required to arrive at an accurate diagnosis and begin appropriate treatment.

The Comprehensive Multi-Faceted Evaluation Process

A definitive polymyositis diagnosis cannot be achieved through a single standalone test. Because many neurological conditions, genetic muscular dystrophies, and drug-induced toxicities can mimic the symptoms of polymyositis, clinicians must utilize a multi-faceted testing panel.

                     [The Multi-Faceted Diagnostic Protocol]
                                        │
        ┌───────────────────┬───────────┴───────────┬───────────────────┐
        ▼                   ▼                       ▼                   ▼
  [Blood Assay Panel]     [Electromyography]     [Muscle MRI Scan]    [Muscle Biopsy]
  - Tracks CK leaks        - Confirms myopathic  - Maps active edema  - The gold standard
  - Screen for anti-Jo-1     potentials           - Guides optimal     - Proves endomysial
    and other MSAs         - Rules out nerves       biopsy site        CD8+ T-cell attack

By piecing together evidence from laboratory assays, electrical nerve pathways, and direct muscle tissue mapping, specialists build a cohesive clinical picture. This thorough process rules out mimicking disorders and confirms a clear inflammatory myopathy profile before initiating high-dose, long-term immunosuppressive therapies.

Advanced Laboratory Panels, Electrical Tests, and Muscle Imaging

To investigate whether a patient’s progressive weakness stems from an autoimmune myopathy, doctors rely on three foundational polymyositis diagnosis screening tools:

Comprehensive Blood Profiles: When acute polymyositis inflammation tears open skeletal muscle fibers, internal cellular components leak directly into the bloodstream. The most critical blood marker is creatine kinase (CK), which frequently registers 10 to 50 times higher than normal parameters. Labs will also test for Myositis-Specific Antibodies (MSAs). While a general positive Antinuclear Antibody (ANA) points to broad autoimmunity, finding specific MSAs like anti-Jo-1, anti-SRP, or anti-Mi-2 confirms an inflammatory myopathy and helps predict long-term lung or heart complications.

Electromyography (EMG): During an EMG, a microscopic needle electrode is inserted directly into the muscle tissue to record electrical impulses at rest and during contraction. In a patient with polymyositis, the EMG displays a distinct pattern of irritable, short, and unusually small electrical signals. This profile proves the weakness originates inside the muscle cells (a myopathy) rather than from failing nerve roots (a neuropathy).

Targeted Magnetic Resonance Imaging (MRI): An MRI scan of large muscle groups (typically the thighs or pelvis) highlights active areas of inflammation, which appear as bright patches of fluid accumulation (edema). Besides mapping out tissue shrinkage (atrophy) or fatty replacement in chronic cases, the primary benefit of a pre-biopsy MRI is that it serves as a visual map. This allows the surgeon to see exactly which muscle bundle is actively inflamed, preventing them from sampling a healthy or completely scarred area.

The Biopsy: The Uncontested Gold Standard for Certainty

While blood work and imaging provide highly suggestive clues, a microscopic muscle biopsy is mandatory and remains the gold standard for a definitive diagnosis. It offers the only direct, physical proof of the immune system’s cellular target.

Proving Endomysial Inflammation: Under a microscope, a biopsy sample shows the exact structural pattern of the autoimmune assault. Pathologists look for a dense gathering of white blood cells—specifically CD8+ cytotoxic T-lymphocytes—actively breaking through cell boundaries to surround and invade individual, non-necrotic muscle fibers. This unique behavior (endomysial inflammation) is a direct reflection of the underlying biological process and provides an indisputable diagnostic match.

Differentiating Myositis Mimics: The biopsy allows doctors to accurately separate polymyositis from related conditions that require vastly different medical care. For instance, in dermatomyositis, the inflammation is located strictly around the nearby blood vessels (perivascular), rather than inside the muscle fibers. In Inclusion Body Myositis (IBM)—a disease that does not respond well to standard steroid treatments—the biopsy will show unique, fluid-filled holes called “rimmed vacuoles,” which are entirely absent in classic polymyositis.

Excluding Non-Inflammatory Disorders: A biopsy prevents severe diagnostic mistakes by ruling out genetic muscular dystrophies. Dystrophies can also cause massively elevated CK levels and muscle weakness, but their biopsy slides show variations in fiber size without the aggressive, localized T-cell invasion that defines an active autoimmune disease.

The role of physical therapy in managing Polymyositis

The role of physical therapy in managing Polymyositis is absolutely crucial for rebuilding muscle strength, improving physical function, preventing joint contractures, and enhancing overall quality of life. This non-pharmacological intervention, representing Fact #9, is considered an essential component of the comprehensive treatment plan, working in tandem with medication. While drugs work to control the underlying inflammation, physical therapy addresses the direct consequence of the disease—the profound muscle weakness and deconditioning. It is a carefully managed process that must be initiated at the right time and tailored to the patient’s current level of disease activity and strength.

The goals and implementation of physical therapy are multifaceted and evolve with the patient’s condition.

During Active Inflammation: In the early, acute phase of the disease when inflammation is high, the focus of therapy is on gentle, passive range-of-motion exercises. This is done to prevent the joints from becoming stiff and the muscles from shortening (a condition known as contracture) due to inactivity. Aggressive strengthening exercises are avoided during this period, as they could potentially worsen muscle damage and inflammation. The therapist plays a key role in educating the patient on energy conservation techniques and the importance of balancing rest with light activity.

As Inflammation Subsides: Once medications begin to control the inflammation and muscle enzyme levels start to fall, a more active rehabilitation program can be initiated. The physical therapist will design a customized, graded exercise program that focuses on gradually strengthening the weakened proximal muscles. This may include isometric exercises (contracting muscles without moving joints), followed by gentle resistance training and functional exercises that mimic daily activities (e.g., practicing standing up from a chair, climbing steps). The key is to progress slowly and listen to the body, avoiding overexertion that could lead to a flare-up.

Long-Term Maintenance and Function: As strength returns, the therapy program will expand to include aerobic conditioning (such as walking or stationary cycling) to improve endurance and combat fatigue. The therapist will also work on balance, coordination, and gait training to improve mobility and reduce the risk of falls. In addition to physical therapy, occupational therapy can help patients learn new ways to perform daily tasks and recommend assistive devices if needed. For patients with dysphagia, speech-language pathologists can provide exercises to strengthen swallowing muscles and recommend dietary modifications to ensure safe eating.

Broader Implications and Distinctions of Polymyositis?

The broader implications of Polymyositis involve its relationship with similar myopathies like Dermatomyositis, its association with serious comorbidities such as interstitial lung disease, and the significant impact that long-term prognosis and lifestyle adjustments have on patient outcomes. Furthermore, understanding these distinctions is crucial for comprehensive diagnosis and effective, holistic management of the condition.

By examining how Polymyositis compares to related disorders and what other health issues it can trigger, patients and healthcare providers can develop a more proactive and personalized treatment strategy that addresses the full spectrum of its effects on the body.

Comparing Polymyositis and Dermatomyositis

While polymyositis and dermatomyositis are both classified as idiopathic inflammatory myopathies sharing progressive muscle weakness, their physical presentation and underlying immune targets are distinctly different.

                    [Comparative Clinical Manifestation Profiles]
                                         │
         ┌───────────────────────────────┴───────────────────────────────┐
         ▼                                                               ▼
   [Polymyositis]                                              [Dermatomyositis]
   - Inflammation confined to muscle tissue                    - Co-existing skin and muscle attack
   - No diagnostic dermatological markers                      - Classic Heliotrope rash & Gottron's papules
   - Endomysial T-cell cellular invasion                       - Perivascular B-cell / CD4+ T-cell infiltration

Dermatological Manifestations: The defining marker of dermatomyositis is a set of highly specific skin rashes. This includes the heliotrope rash (a distinct purplish discoloration and swelling of the eyelids) and Gottron’s papules (reddish, raised bumps over the knuckles, elbows, or knees). Patients may also display a “shawl sign” across the shoulders or a “V-sign” on the upper chest. In contrast, polymyositis features no skin involvement whatsoever; its autoimmune inflammation is entirely confined to the internal skeletal muscle tissue.

Muscle Involvement: Despite the skin differences, the pattern of muscle weakness is nearly identical in both conditions. It is symmetrical and targets the proximal muscles closest to the trunk (hips, thighs, neck, and shoulders). This leaves patients with the same functional struggles, such as rising from chairs or lifting their arms.

Distinct Biopsy Signatures: Because polymyositis lacks visual skin cues, a polymyositis diagnosis relies heavily on a muscle biopsy. Under a microscope, polymyositis displays an endomysial pattern where cytotoxic T-cells directly invade healthy muscle fibers. Dermatomyositis tissue, however, shows a perivascular pattern, meaning the inflammation primarily clusters around blood vessels at the outer edge of the muscle bundles.

Systemic Comorbidities and Organ Involvement

Polymyositis is a systemic autoimmune disease. The same misdirected immune response that targets skeletal tissue can expand to damage other vital organ systems.

Interstitial Lung Disease (ILD): This is one of the most serious complications associated with polymyositis. The underlying autoimmune process triggers progressive inflammation and scarring (fibrosis) of the delicate tissue between the lung’s air sacs. This causes the lungs to stiffen, leading to a persistent dry cough, profound fatigue, and worsening shortness of breath. Because ILD can heavily impact a patient’s prognosis, pulmonologists perform baseline and routine screenings using high-resolution chest CT scans and pulmonary function tests (PFTs).

Malignancy Risk: Clinical data shows a recognized, elevated risk of cancer in patients with inflammatory myopathies, particularly within the first few years of diagnosis. This link requires immediate, age-appropriate cancer screenings covering potential ovarian, lung, pancreatic, and colorectal malignancies. It is hypothesized that the immune system’s response to an un-detected tumor can accidentally cross-react with healthy muscle proteins, triggering polymyositis symptoms.

Cardiovascular and Esophageal Strain: Inflammation can target the myocardium (heart muscle), leading to myocarditis, heart failure, or irregular heart rhythms (arrhythmias) that require cardiac monitoring. Additionally, if the disease weakens the muscles of the pharynx and upper esophagus, patients develop swallowing difficulties (dysphagia), which increases the risk of food aspiration, malnutrition, and aspiration pneumonia.

Long-Term Prognosis and Rehabilitation

The long-term outlook for an individual with polymyositis varies based on age, the severity of the initial muscle damage, and how quickly immunosuppressive therapy is started. While there is no definitive cure, modern medical strategies allow many patients to achieve long-term remission.

                    [Multidisciplinary Long-Term Management]
                                       │
        ┌──────────────────────────────┼──────────────────────────────┐
        ▼                              ▼                              ▼
[Medical Remission]          [Physical Therapy]           [Comorbidity Surveillance]
- High-dose Corticosteroids  - Structured, dynamic plan   - Routine Pulmonary Function Tests
- Steroid-sparing agents     - Restores physical control  - Cardiovascular tracking
- Lowers active muscle labs  - Rebuilds lost endurance    - Age-appropriate cancer screens

First-line treatment typically begins with high-dose corticosteroids (such as prednisone) to quickly suppress the aggressive T-cell attack and bring down elevated muscle enzymes. Over time, doctors transition patients to steroid-sparing immunosuppressants (like methotrexate or azathioprine) to maintain control while avoiding long-term steroid side effects.

A custom-tailored physical and occupational therapy program is a cornerstone of long-term care. While complete rest is necessary during an acute flare, prolonged inactivity causes muscle wasting (atrophy). A structured exercise regimen helps rebuild muscle strength, preserves joint range of motion, and improves endurance, helping patients regain their functional independence.

Evidence-Based Lifestyle Support Strategies

Adopting targeted lifestyle changes can play a valuable supportive role alongside medical treatments, helping to lower systemic inflammation and manage daily fatigue.

Implementing an Anti-Inflammatory Diet

Adjusting your nutrition can help manage the body’s overactive immune pathways. Focus your meals on anti-inflammatory whole foods while limiting processed options that can drive inflammation.

Nutritional Supplementation: Because long-term corticosteroid use can cause bone thinning (osteoporosis), physicians frequently recommend supplementing your diet with Calcium and Vitamin D to protect bone density.

Energy Conservation and Pacing

Profound, exhausting fatigue is a hallmark symptom of polymyositis. Managing your day through pacing helps prevent a “boom-and-bust” cycle—where overexertion on a good day leads to days of severe exhaustion later.

Break large household chores into smaller tasks, sit down while cooking or grooming to save energy, and use assistive tools when needed to reduce joint and muscle strain.

Stress Reduction and Rest

Chronic emotional and physical stress triggers the release of inflammatory cytokines, which can worsen autoimmune symptoms. Incorporating daily stress-management habits—such as mindfulness, deep breathing exercises, or meditation—helps calm the nervous system and supports your overall recovery.

Conclusion

Polymyositis is more than temporary muscle soreness because it involves ongoing inflammation that can weaken important skeletal muscles. The condition often affects both sides of the body and may make everyday movements harder over time. Diagnosis may include blood tests, muscle enzyme testing, imaging, electromyography, and sometimes muscle biopsy. With proper treatment, physical therapy, and regular monitoring, many people can manage polymyositis more effectively and reduce the risk of long-term muscle damage.

Read more: 7 Things to Know About Clotting Factors and How Blood Clots Form

Frequently Asked Questions

1. What is polymyositis?

Polymyositis is an inflammatory muscle disease that causes weakness in the skeletal muscles used for movement. It usually affects muscles close to the center of the body, such as the shoulders, hips, thighs, upper arms, and neck. The weakness often develops gradually over weeks or months. It is considered an autoimmune-related condition because the immune system is involved in muscle inflammation.

2. What are the early symptoms of polymyositis?

Early symptoms of polymyositis often include gradual muscle weakness, fatigue, and difficulty with everyday movements. A person may struggle to climb stairs, stand up from a chair, lift objects, or reach overhead. Muscle pain or tenderness can happen, but weakness is usually the main concern. Symptoms often affect both sides of the body rather than just one isolated muscle.

3. How is polymyositis diagnosed?

Polymyositis is diagnosed through a combination of symptoms, physical examination, blood tests, imaging, nerve and muscle studies, and sometimes muscle biopsy. Blood tests may show elevated muscle enzymes, such as creatine kinase. MRI or electromyography may help detect muscle inflammation or abnormal muscle activity. A muscle biopsy may be used to confirm the diagnosis and rule out other muscle disorders.

4. Can polymyositis affect breathing or swallowing?

Yes, polymyositis can sometimes affect muscles involved in swallowing or breathing. Swallowing problems may cause choking, coughing during meals, or a feeling that food is stuck. Breathing problems may occur if respiratory muscles or the lungs are involved. These symptoms should be discussed with a healthcare provider because they can become serious.

5. How is polymyositis treated?

Treatment for polymyositis usually focuses on reducing inflammation and improving muscle strength. Corticosteroids are often used first, and other immune-suppressing medicines may be added if needed. Physical therapy can help maintain mobility, rebuild strength, and reduce disability. Treatment plans should be individualized and monitored by specialists, often including a rheumatologist or neurologist.

Sources

• Polymyositis: What It Is, Causes, Symptoms & Treatment (Cleveland Clinic)
• Inflammatory Myopathies (National Institute of Neurological Disorders and Stroke / BrainFacts)
• Idiopathic Inflammatory Myopathies (Merck Manual Professional Version)
• Idiopathic Inflammatory Myopathies (Merck Manual Consumer Version)
• Diagnosis, Pathogenesis and Treatment of Myositis (PMC)
• Diagnosis and Treatment of Inflammatory Myopathy (PMC)
• Polymyositis and Dermatomyositis – Challenges in Diagnosis and Management (PMC